Ofra Benny
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 6
- Biomaterials 12
- Nanoparticle-Based Drug Delivery 11
- Co-authors
- Robert J. D’AmatoIrit AdiniLauren BazinetJudah FolkmanMarcelle MachlufElke PravdaTal SternOfer Fainaru
- Journals
- International Journal of Molecular Sciences (4 papers)The FASEB Journal (3 papers)Clinical Cancer Research (2 papers)Scientific Reports (2 papers)Cancers (2 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Ofra Benny
64 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 120
- Pharmaceutical Science 181
- Biomaterials 367
- Reproductive Medicine 139
- Obstetrics and Gynecology 127
- Biomedical Engineering 552
Countries citing papers authored by Ofra Benny
This map shows the geographic impact of Ofra Benny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofra Benny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofra Benny more than expected).
Fields of papers citing papers by Ofra Benny
This network shows the impact of papers produced by Ofra Benny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofra Benny. The network helps show where Ofra Benny may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ofra Benny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 20 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 14 | |
| 8 | 2022 | 7 | |
| 9 | 2020 | 11 | |
| 10 | 2020 | 20 | |
| 11 | 2020 | 10 | |
| 12 | Expeditious bilateral murine fundus fluorescein angiography (FFA): Maximizing optical imagery with a transportable digital camera | 2017 | 3 |
| 13 | 2017 | 13 | |
| 14 | 2017 | 1 | |
| 15 | 2016 | 62 | |
| 16 | 2015 | 20 | |
| 17 | 2013 | 7 | |
| 18 | 2011 | 70 | |
| 19 | 2010 | 24 | |
| 20 | 2009 | 42 |
About Ofra Benny
Ofra Benny is a scholar working on Pharmaceutical Science, Biomaterials, Ophthalmology, Cell Biology and Biomedical Engineering, having authored 67 papers that have together received 1.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (11 papers), Angiogenesis and VEGF in Cancer (11 papers), 3D Printing in Biomedical Research (11 papers), Innovative Microfluidic and Catalytic Techniques Innovation (9 papers), Retinal Diseases and Treatments (6 papers), Advanced Drug Delivery Systems (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Cellular Mechanics and Interactions (5 papers). The work is most often cited by research in Pharmaceutical Science (181 citations), Biomaterials (367 citations), Reproductive Medicine (139 citations), Obstetrics and Gynecology (127 citations) and Biomedical Engineering (552 citations). Ofra Benny has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Robert J. D’Amato, Irit Adini, Lauren Bazinet, Judah Folkman, Marcelle Machluf, Elke Pravda, Tal Stern, Ofer Fainaru, Avner Adini and Ouri Schwob. Their work appears in journals such as International Journal of Molecular Sciences, The FASEB Journal, Clinical Cancer Research, Scientific Reports and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.